Avondale Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVONDALE PHARMS, and what generic and branded alternatives to AVONDALE PHARMS drugs are available?
AVONDALE PHARMS has four approved drugs.
Summary for Avondale Pharms
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Avondale Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avondale Pharms | NIACOR | niacin | TABLET;ORAL | 040378-001 | May 3, 2000 | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Avondale Pharms | DIFLORASONE DIACETATE | diflorasone diacetate | CREAM;TOPICAL | 075187-001 | Mar 30, 1998 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Avondale Pharms | MELOXICAM | meloxicam | SUSPENSION;ORAL | 021530-001 | Jun 1, 2004 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Avondale Pharms | DIFLORASONE DIACETATE | diflorasone diacetate | OINTMENT;TOPICAL | 075374-001 | Apr 27, 1999 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Avondale Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Avondale Pharms | MELOXICAM | meloxicam | SUSPENSION;ORAL | 021530-001 | Jun 1, 2004 | 6,184,220*PED | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
